Your browser doesn't support javascript.
loading
Strategies for improving access to clinical trials by teenagers and young adults with cancer: A qualitative study of health professionals' views.
Hart, Ruth I; Boyle, Dorothy; Cameron, David A; Cowie, Fiona J; Hayward, Larry; Heaney, Nicholas B; Jesudason, Angela B; Lawton, Julia.
Afiliação
  • Hart RI; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Boyle D; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
  • Cameron DA; NHS Research Scotland Cancer Lead and Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Cowie FJ; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Hayward L; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
  • Heaney NB; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Jesudason AB; Department of Paediatric Haematology and Oncology, Royal Hospital for Sick Children, Edinburgh, UK.
  • Lawton J; Usher Institute, University of Edinburgh, Edinburgh, UK.
Eur J Cancer Care (Engl) ; 30(3): e13408, 2021 May.
Article em En | MEDLINE | ID: mdl-33474755
ABSTRACT

OBJECTIVE:

Few teenagers and young adults (TYA) with cancer participate in clinical trials. Lack of opportunity has been identified as a major barrier. We canvassed health professionals' views on how TYA's access to trials might be improved.

METHODS:

We interviewed 35 professionals with responsibility for delivering or facilitating cancer care and/or clinical trials. We analysed data using a qualitative descriptive approach.

RESULTS:

Interviewees viewed improving TYA's access to trials as challenging, but possible. They reframed the problem as one of rare disease and surmised that modifying the organisation, administration and resourcing of research (and care) might expand opportunities for both TYA and other patients with low volume conditions. Proposals coalesced around four themes consolidating the pool of patients; streamlining bureaucratic requirements; investing in the research workforce; and promoting pragmatism in trial design.

CONCLUSION:

Accounts suggest there is scope to improve access to trials by TYA with cancer and other patients with rare diseases. Though re-configuring care, research and resource frameworks would present substantial challenges, doing nothing would also have costs. Change will require the support of a range of stakeholders, and agreement as to the best way forward. Further work, such as priority setting exercises, may be necessary to reach a consensus.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Acessibilidade aos Serviços de Saúde / Neoplasias Tipo de estudo: Guideline / Qualitative_research Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Acessibilidade aos Serviços de Saúde / Neoplasias Tipo de estudo: Guideline / Qualitative_research Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article